(173 days)
Not Found
No
The summary describes a standard oscillometric blood pressure monitor using a non-invasive algorithm, with no mention of AI or ML in the device description, performance studies, or key metrics.
No
This device is for measuring blood pressure and pulse rate, which are diagnostic indicators, not for treating a disease or condition. Therapeutic devices provide treatment.
Yes
The device is intended to "measure the systolic blood pressure as well as the pulse rate of adult person," which are measurements used to aid in diagnosis.
No
The device description explicitly states it is a "battery powered automatic non-invasive blood pressure monitor" and mentions hardware components like inflation and deflation mechanisms. It also includes non-clinical data related to electrical safety and biocompatibility, which are associated with hardware.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The Electronic Blood Pressure Monitor measures blood pressure and pulse rate non-invasively on the upper arm. It does not analyze samples taken from the body.
- Intended Use: The intended use is to measure physiological parameters (blood pressure and pulse rate) directly from the patient.
Therefore, this device falls under the category of a non-invasive medical device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Electronic Blood Pressure Monitor is intended to measure the systolic blood pressure as well as the pulse rate of adult person via non-invasive oscillometric technique at medical facilities or at home.
Product codes
DXN
Device Description
JPD-HA120 and JPD-HA121 Electronic Blood Pressure Monitor is a battery powered automatic non-invasive blood pressure monitor. It can automatically complete the inflation, deflation and measurement, which can measure systolic and diastolic blood pressure and pulse rate of the adult person at upper arm within its claimed range and accuracy via the oscillometric technique. User can select the unit of the measurement: mmHg or kPa.
The device has the data storage function in order for data reviewing, including the systolic pressure, diastolic pressure, pulse rate and measurement time. The proposed JPD-HA120 and JPD-HA121 Electronic Blood Pressure Monitor share the same software, measurement principle and NIBP algorithm. The main differences are product appearance.
The proposed device is intended to be used in medical facilities or at home. And the effectiveness of this sphygmomanometer has not been established in pregnant (including pre-eclamptic) patients.
The product is provided non-sterile, and not to be sterilized by the user prior to use.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
upper arm
Indicated Patient Age Range
Adult
Intended User / Care Setting
Home Use and Medical Facilities
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance data includes "Non-Clinical Data" and "Clinical Data".
Non-Clinical Data:
Biocompatibility testing: The biocompatibility evaluation for the JPD-HA120&JPD-HA121 Electronic Blood Pressure Monitor and the NIBP CUFF were conducted in accordance with the International Standard ISO 10993-1. The tests included: Cytotoxicity, Skin Sensitization, Skin Irritation.
Electrical safety and electromagnetic compatibility (EMC): The system complies with the IEC 60601-1: 2012 and IEC 60601-1-2: 2014.
Bench Testing: The system complies with the IEC 60601-1-11: 2010, ISO 80601-2-30: 2009 for performance effectiveness.
Software Verification and Validation Testing: Conducted as recommended by FDA's Guidance for Industry and FDA Staff. The software was considered a "major" level of concern.
Clinical data: Clinical testing is conducted per ISO 81060-2: 2013 Non-invasive sphygmomanometers - Part 2: Clinical validation of automated measurement type.
Key Results: Based on the non-clinical and clinical performance, the subject devices were found to have a safety and effectiveness profile that is similar to the predicate device. Verification and validation testing passed pre-specified criteria.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1130 Noninvasive blood pressure measurement system.
(a)
Identification. A noninvasive blood pressure measurement system is a device that provides a signal from which systolic, diastolic, mean, or any combination of the three pressures can be derived through the use of tranducers placed on the surface of the body.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
March 3, 2019
Shenzhen Jumper Medical Equipment Co., Ltd. Jinhui Tang Regulatory Manager D Building, No. 71, Xintian Road, Fuyong Street, Baoan District, Shenzhen, 518103, CHINA
Re: K182495
Trade/Device Name: Electronic Blood Pressure Monitor, models JPD-HA120 and JPD-HA121 Regulation Number: 21 CFR 870.1130 Regulation Name: Noninvasive Blood Pressure Measurement System Regulatory Class: Class II Product Code: DXN Dated: January 23, 2019 Received: January 28, 2019
Dear Jinhui Tang:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmp/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
1
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Stephen C. Browning -S5
for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K182495
Device Name
Electronic Blood Pressure Monitor, models JPD-HA120 and JPD-HA121
Indications for Use (Describe)
The Electronic Blood Pressure Monitor is intended to measure the systolic blood pressure as well as the pulse rate of adult person via non-invasive oscillometric technique at medical facilities or at home.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ------------------------------------------------- | -- |
Prescription Use (Part 21 CFR 801 Subpart D)
|X | Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary
Prepared in accordance with the requirements of 21 CFR Part 807.92
| 1. Submitter: | Shenzhen Jumper Medical Equipment Co., Ltd. | ||||
|---|---|---|---|---|---|
| D Building, No.71, Xintian Road, Fuyong Street, Baoan District, 518103, | |||||
| Shenzhen, P.R. China | |||||
| Tel.: +86 -755- 2669 2192 | |||||
| Fax: +86 -755- 2685 2025 | |||||
| Contact Person: | Jinhui Tang | ||||
| Prepare date: | 2018-09-04 | ||||
| 2. Device name | |||||
| and classification: | Device Name: Electronic Blood Pressure Monitor | ||||
| Models: JPD-HA120 and JPD-HA121 | |||||
| Classification Name: | |||||
| 21 CFR 870.1130 | |||||
| Noninvasive Blood Pressure Measurement System | |||||
| Product code: DXN | |||||
| Regulatory Class: Class II | |||||
| 3. Reason for | |||||
| Submission | New Application. | ||||
| 4. Predicate | |||||
| Device(s): | Shenzhen Pango Electronic Co., Ltd., PG-800B36 Electronic Blood Pressure | ||||
| Monitor / K170151 | |||||
| 5. Device | |||||
| Description: | JPD-HA120 and JPD-HA121 Electronic Blood Pressure Monitor is a battery | ||||
| powered automatic non-invasive blood pressure monitor. It can automatically | |||||
| complete the inflation, deflation and measurement, which can measure systolic and | |||||
| diastolic blood pressure and pulse rate of the adult person at upper arm within its | |||||
| claimed range and accuracy via the oscillometric technique. User can select the unit | |||||
| of the measurement: mmHg or kPa. | |||||
| The device has the data storage function in order for data reviewing, including the | |||||
| systolic pressure, diastolic pressure, pulse rate and measurement time. The proposed | |||||
| JPD-HA120 and JPD-HA121 Electronic Blood Pressure Monitor share the same | |||||
| software, measurement principle and NIBP algorithm. The main differences are | |||||
| product appearance. | |||||
| The proposed device is intended to be used in medical facilities or at home. And the | |||||
| effectiveness of this sphygmomanometer has not been established in pregnant | |||||
| (including pre-eclamptic) patients. | |||||
| The product is provided non-sterile, and not to be sterilized by the user prior to use. |
4
The Electronic Blood Pressure Monitor is intended to measure the systolic and 6. Indications for diastolic blood pressure as well as the pulse rate of adult person via non-invasive Use: oscillometric technique at medical facilities or at home.
7. Predicate Device Comparison
Comparison to the predicate devices, the subject device has same intended use, similar product design, same performance effectiveness, performance safety as the predicate device.
Please refer to following table to find differences between the subject device and predicate device. All the differences do not affect the basic design principle, usage, effectiveness and safety of the subject device. And no new question is raised regarding the product's effectiveness and safety.
| ITEM | Proposed Device
JPD-HA120 and JPD-HA121 | Predicate Device
PG-800B36/ K170151 | Comparison
Result |
|-----------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------|
| Manufacture | Shenzhen Jumper Medical
Equipment Co., Ltd. | Shenzhen Pango Electronic Co.,
Ltd. | --- |
| Intended Use | The Electronic Blood Pressure
Monitor is intended to measure the
systolic and diastolic blood pressure
as well as the pulse rate of adult
person via non-invasive
oscillometric technique at medical
facilities or at home. | The Electronic Blood Pressure
Monitor is intended to measure the
systolic and diastolic blood
pressure as well as the pulse rate of
adult person via non-invasive
oscillometric technique in which an
inflatable cuff is wrapped around
the upper arm. It can be used at
medical facilities or at home. The
intended arm circumference
includes 22 cm32 cm and 3242 cm. | Different |
cm
| Contraindications | Not Known | Not Known | Same |
| Clinical Use | Medical Facilities and Home Use | Medical Facilities and Home Use | Same |
| Patient
Population | Adult | Adult | Same |
| Measurement
Type | Upper arm | Upper arm | Same |
| Measurement
Principle | Oscillometric | Oscillometric | Same |
| Components | LCD / Key / Cuff / MCU / Pump /
Batteries | LCD / Key / Cuff / MCU / Pump /
Batteries | Same |
| Power Source | 4x1.5V | 4x1.5V | Same |
| Physical
Dimensions | Approx: 138 mm(Length)x120
mm(Width)x59 mm(Height) | Approx: 140 mm(W)x100
mm(H)x50 mm(D) | Different |
| Weight | Approx: 483.8 g, excluding battery | Approx: 420 g, excluding battery | Different |
| Measurement
Range | Blood
Pressure
30255 mmHg280 mmHg
Pulse Rate
40-199 bpm | Blood
Pressure
30
Pulse
Rate
40-199 bpm | Different |
| Accuracy | Static
Pressure
$\pm$ 3 mmHg
Pulse
$\pm$ 5% | Static
Pressure
$\pm$ 3 mmHg
Pulse
$\pm$ 5% | Same |
| Arm
Circumference | 22 cm36 cm | 22 cm32 cm | Different |
| Patient Contact
Material | Cuff – Terylene
Enclosure - ABS
Key - PMMA | Cuff – Nylon
Enclosure - ABS
Key - ABS | Different |
| Applied
Standards | IEC 60601-1
IEC 60601-1-2
IEC 60601-1-11
80601-2-30:2009
81060-2:2013 | IEC 60601-1
IEC 60601-1-2
IEC 60601-1-11
80601-2-30:2009
81060-2:2013 | Same |
| Operation
Environments | + 5°C~ + 40°C, 15%RH90%RH106 kPa | + 5°C~ + 40°C, 15%RH
Atmospheric Pressure: 70 kPa93%RH106 kPa | Different |
Atmospheric Pressure: 50 kPa
| Storage
Environments | - 20°C~ + 55°C, 10%RH93%RH106 kPa | - 20°C~ + 55°C, 0%RH
Atmospheric Pressure: 70 kPa93%RH106 kPa | |
Atmospheric Pressure: 50 kPa
Table 1 Comparison between the predicate PG-800B36 and the subject device
5
As seen in the comparison tables, the subject and predicate devices have almost the same design features and performance specifications. The main technological differences between the subject and predicate devices are minor differences, including the Physical Dimensions, Arm Circumference and Operation & Storage Environments, which do not raise different questions of safety or effectiveness. Moreover, as demonstrated in the non-clinical and clinical testing, the different technological characteristics do not affect the safety and effectiveness of the system.
8. Performance Testing:
Performance data includes "Non-Clinical Data" and "Clinical Data", brief description of which are shown as below.
Non-Clinical Data:
The following performance data were provided in support of the substantial equivalence determination.
Biocompatibility testing
The biocompatibility evaluation for the JPD-HA120&JPD-HA121 Electronic Blood Pressure Monitor and the NIBP CUFF were conducted in accordance with the International Standard ISO 10993-1 "Biological Evaluation of Medical Devices - Part 1: Evaluation and Testing Within a Risk Management Process," as recognized by FDA. The worst case of the whole system is considered tissue contacting for duration of less than 24 hours. And the battery of testing included the following tests:
- □ Cytotoxicity
- □ Skin Sensitization
- □ Skin Irritation
Electrical safety and electromagnetic compatibility (EMC)
Electrical safety and EMC testing were conducted on the JPD-HA120 and JPD-HA121 Electronic Blood Pressure Monitor, consisting of all the modules and accessories in the system. The system complies with the IEC 60601-1: 2012 Medical electrical equipment Part 1: General requirements for basic safety and essential performance for safety and the IEC 60601-1-2: 2014 Medical electrical equipment – Part 1-2: General requirements for basic safety and essential performance – Collateral Standard: Electromagnetic disturbances - Requirements and tests standard for EMC.
Bench Testing
Bench testing was conducted on the JPD-HA120 and JPD-HA121 Electronic Blood Pressure Monitor, consisting of all the accessories in the system. The system complies with the IEC 60601-1-11: 2010 MEDICAL ELECTRICAL EQUIPMENT-Part 1-11: General requirements for basic safety and
6
essential performance –Collateral Standard: Requirements for medical electrical equipment and medical electrical systems used in the home healthcare environment. ISO 80601-2-30: 2009 Medical electrical equipment — Part 2-56: Particular requirements for basic safety and essential performance of automated non-invasive sphygmomanometers standards for performance effectiveness.
Software Verification and Validation Testing
Software verification and validation testing were conducted and documentation was provided as recommended by FDA's Guidance for Industry and FDA Staff. "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices." The software for this device was considered as a "major" level of concern, since a failure or latent flaw in the software could directly result in serious injury or death to the patient or operator.
Clinical data:
Clinical testing is conducted per ISO 81060-2: 2013 Non-invasive sphygmomanometers - Part 2: Clinical validation of automated measurement type.
Summary
Based on the non-clinical and clinical performance as documented in the device development, the subject devices were found to have a safety and effectiveness profile that is similar to the predicate device.
9. Conclusion:
Verification and validation testing was conducted on the subject device and all testing passed pre-specified criteria. This premarket notification submission demonstrates that the Jumper Electronic Blood Pressure Monitor is substantially equivalent to the predicate devices.